• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...
Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback